Ensuring Timely Access to Generics Act of 2025

# Ensuring Timely Access to Generics Act of 2025 - Summary **What the Bill Does** The Ensuring Timely Access to Generics Act of 2025 aims to speed up the availability of generic medications to consumers. Generic drugs are lower-cost versions of brand-name medications that contain the same active ingredients. This bill would address delays that sometimes occur in the generic drug approval and market entry process, making these affordable alternatives available to patients more quickly. **Who It Affects** The bill primarily affects patients who rely on or could benefit from generic medications, as well as generic drug manufacturers, brand-name pharmaceutical companies, and the FDA (the federal agency that approves medications).

Consumers would potentially benefit from faster access to cheaper drug alternatives, while the pharmaceutical industry would face changes to current procedures. **Current Status** As of now, the bill (S 3014) has been introduced in the Senate by Senator Jeanne Shaheen (D-NH) but remains in committee, meaning it hasn't yet been debated or voted on by the full Senate. The specific provisions of the bill—the detailed rules or requirements it would create—were not available in the provided information.